Altium Capital Management is a leading alternative investment manager based in New York. With a primary focus on the Healthcare industry, Altium specializes in providing growth capital to both private and public companies that are developing innovative technologies for human health. Led by our experienced CEO, Jacob Gottlieb, who has over 20 years of healthcare investment experience, we have built a team of MDs, PhDs, scientific professionals, and skilled fund managers who work together to uncover unique investment insights.

Our investment universe mainly concentrates on therapeutics, including private ventures, small-cap, and micro-cap public companies. We seek out companies with transformative catalysts in the pipeline, many of which are raising capital for the first time. Additionally, Altium helps these companies attract additional capital through our extensive network of like-minded investors.

Our rigorous research and due diligence enable us to invest with confidence in promising new technologies. With a commitment to long-term partnerships and multiple rounds of financing, we support early-stage ventures in the pre-clinical development phases. Altium Capital Management prides itself on fostering a collaborative team approach, positive culture, and firm-wide integrity.

We offer intellectual growth, career enrichment, and opportunities for our talented and motivated professionals